First Advantage Takes Gold in HRD HR Service Provider Awards for Second Year in a Row

Global Leader Received Top Honors in Pre-Employment Screening and Psychometric Assessment Category

ATLANTA and SYDNEY, Australia, Nov. 16, 2020 (GLOBE NEWSWIRE) — Today, First Advantage, a global leader in background check solutions, announced that it received a Gold HR Service Provider Award from Human Resources Director (HRD) magazine for pre-employment screening. This is the company’s second consecutive win.

HRD shared, “Finding a dependable service provider can be quite the daunting task for HR professionals. From an impressive array of vendors offering their expertise, HR professionals need to choose the one that suits their company’s unique needs. By outsourcing some of the day-to-day office requirements to a trusted partner, the HR team can focus on the company’s long-term business strategy and goals.”

As such, the annual awards program aims to assist HR professionals with this task by recognizing HR service providers across eight categories, including screening and assessment. A panel of judges reviewed all entrants, with the top three submissions in each category receiving gold, silver and bronze HRD HR Service Provider Awards, respectively.

With regard to First Advantage, HRD commented, “It has the ability to provide effortless, global background check services with the right technology – from criminal record searches; education, employment, and professional license verifications; global sanction searches; credit checks; to medical screening; and more. And unlike other background screening organizations that purport to be global, First Advantage has a truly global infrastructure.”

James T. Heeney, vice president, Head of Australia and New Zealand for First Advantage, said, “While 2020 presented its challenges, First Advantage remained steadfast in our role as a global technology partner, providing our customers with solutions and services designed to meet today’s business conditions. It’s an honor to receive the Gold HR Service Provider Award for the second year in a row, as we continue to navigate these unique times.”

To read more, visit https://www.hcamag.com/au/news/special-reports/hr-service-provider-awards-2020/first-advantage/238547.

A
bout First Advantage

First Advantage provides comprehensive background screening, identity and information solutions that give employers access to actionable information that results in faster, more accurate people decisions. With an advanced global technology platform and superior customer service delivered by experts who understand local markets, First Advantage helps customers around the world build fully scalable, configurable screening programs that meet their unique needs. Headquartered in Atlanta, Georgia, First Advantage has offices throughout North America, Europe, Asia and the Middle East.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/959b392f-9944-4ef8-b0ce-5e2a5a8f7d04



Note to editors: Trademarks and registered trademarks referenced herein remain the property of their respective owners.

Media Contact: 
Anita Khoshabeh
First Advantage
[email protected] 
612-9017-4321

TeneoFour’s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals

NEWARK, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — Teneobio, Inc. and its affiliate TeneoFour, Inc. announced today a Nature Metabolism publication (https://www.nature.com/articles/s42255-020-00298-z) of a proof of concept study by the Chini Laboratory (Mayo Clinic’s campus in Rochester, Minnesota) describing the rejuvenation of energy metabolism in aged mice undergoing therapy with Teneobio’s CD38 blocker.

The presented findings demonstrate that chronic inflammation (“inflammaging”) mediated by senescent cells induces a CD38-mediated decline in precursors involved in cellular health and energy metabolism. Specific inhibition of CD38 using Teneobio’s CD38 specific antibody raised levels of these precursors and restored nicotinamide nucleotide homeostasis in aged animals.

Wim van Schooten, Chief Scientific Officer at Teneobio, said, “Boosting NAD+ levels and Sirtuin activity are known for their strong anti-inflammatory and tissue protective effects. Repair of inflammation-related decline of NAD+ could be an effective therapy of aging -associated diseases such as fibrosis and metabolic disorders. Teneobio plans to initiate clinical trials with this exciting new anti-CD38 therapeutic in the first half of 2021.”

About
Teneobio
, Inc.

Teneobio, Inc. is a clinical stage biotechnology company developing a new class of biologics, Human Heavy-Chain Antibodies (UniAb®), for the treatments of cancer, autoimmunity, and infectious diseases. Teneobio’s discovery platform, TeneoSeek, comprises genetically engineered animals (UniRat® and OmniFlic®), next-generation sequencing, bioinformatics and high-throughput vector assembly technologies. TeneoSeek rapidly identifies large numbers of unique binding molecules specific for therapeutic targets of interest. Versatile antibody variable domains (UniDab®) derived from UniAb® can be assembled into multi-specific and multivalent therapeutic proteins, surpassing limitations of conventional antibody therapeutics. Teneobio’s “plug-and-play” heavy chain antibody platform includes a diverse set of immunomodulatory antibodies for therapeutics with optimal efficacy and reduced toxicity.

Teneobio partners include AbbVie, Janssen, GSK, Kite and Poseida, Intellia and ArsenalBio.  For more information, please visit www.teneobio.com.

About TeneoFour, Inc.

TeneoFour, Inc. is a spinout of Teneobio, Inc. developing anti-CD38 heavy chain antibodies that block the enzyme functions of CD38. TeneoFour, Inc. owns all rights to products and intellectual property generated at Teneobio, Inc. regarding human heavy chain antibodies specific for CD38.

Company Inquiries for
Teneobio
, Inc.
and TeneoFour, Inc.

Omid Vafa, Chief Business Officer
[email protected]



New Book Calls for a New American Political Party That Puts the Focus Back on the Needs of the Middle Class

Military veteran and criminal defense attorney James Weart explores how to reinstate U.S. values in government amidst serious party conflicts in ‘Common Sense: A Real Party Movement’

ROGERSVILLE, Tenn., Nov. 16, 2020 (GLOBE NEWSWIRE) — This election year has revealed that the two-party system has contributed to stark division among Americans. With all eyes on newly elected state and federal officials, James Weart, a proud American, military veteran and criminal defense attorney with over forty years of experience, shares why now is the best time to establish a third political party into government. His new book, “Common Sense: A Real Party Movement” analyzes American history from the original thirteen colonies to the formulation of U.S. government to narrow in on how politics reached this boiling point and what changes can be made to the party system to save the country from further political divide.

Exploring the country’s historic roots, Weart shares warnings from George Washington in 1797 regarding the realities of governmental stagnation and deadlock caused by a two-party system. Knowledge of America’s fascinating history shines a light on the balance another political party could have on the middle class who, Weart notes, are not properly represented by the Republican and Democratic parties.

Weart explains how the rich and dominant elite run the two political parties as an oligarchy instead of a democracy and ignore the struggles of the middle class who elected them to power. He proposes that a new party, the Real Party of America, would better represent the average citizen and renew traditional founding values.

With a focus on curtailing government spending, resolving the COVID-19 crisis, repairing infrastructure and providing affordable health care, the Real Party of America would restore the country with elected officials that truly represent the middle class.

Providing honest findings on the country’s current political standing, “Common Sense: A Real Party Movement” drives readers to explore solutions to restore America’s moral compass and educate themselves on the importance of better representation for the future of this country.

 

“Common Sense: A Real Party Movement”

By James Weart, Juris Doctor

ISBN: 978-1-6632-1024-1 (softcover); 978-1-6632-1023-4 (electronic)

Available at the iUniverse Online Bookstore, Amazon and Barnes & Noble

 

About the author

James C. Weart was raised in a military family that moved regularly and thus saw different parts of the country. In 1970, he graduated from Stetson University with a Bachelor of Arts in History and Political Science. He was commissioned as a Second Lieutenant in the U.S. Army and assigned to the Engineer Corps. He graduated from Mercer Law School with a Juris Doctor in 1976, later becoming a successful criminal defense lawyer in Orlando, Florida for 42 years. In 2017 and 2018 he was proclaimed one of the ten best criminal lawyers in the State of Florida by several national organizations. He is retired and currently resides in the mountains of Eastern Tennessee with his wife and three dogs.

iUniverse, an Author Solutions, LLC, self-publishing imprint, is the leading book marketing, editorial services, and supported self-publishing provider. iUniverse recognizes excellence in book publishing through the Star, Rising Star and Editor’s Choice designations—self-publishing’s only such awards program. iUniverse is headquartered in Bloomington, Indiana. For more information or to publish a book, please visit iuniverse.com or call 1-800-AUTHORS.

Attachment



LAVIDGE
480-306-7065
[email protected]

ECOFIBRE LIMITED Level 1 American Depository Receipt Program

Georgetown, Kentucky, Nov. 16, 2020 (GLOBE NEWSWIRE) — Ecofibre Limited (Ecofibre, Company) (ASX: EOF, ADR: EOFBY) today announced it will sponsor an American Depository Receipt (ADR) program to improve access for investors in the United States (U.S.). 

Deutsche Bank Trust Company Americas (Deutsche) has been appointed depositary bank for the program which became available for trading in the U.S. on Thursday, November 12, 2020. Ecofibre’s ADR will trade in the U.S. over-the-counter (OTC) market under the symbol EOFBY. One Ecofibre ADR represents four existing Ecofibre ordinary shares. 

The ADR program does not involve the issuance of new shares or the raising of new capital by the Company. 

ADRs allow U.S. investors to buy shares in foreign companies through U.S. registered securities without the need for cross-border or cross-currency transactions. They are priced in U.S. dollars and can be traded like shares of U.S. based companies. 

Ecofibre’s ordinary shares may also continue to trade on the OTC market in the U.S. as foreign securities under the ticker code EOFBF. 

Ecofibre will remain a member company of the Nasdaq International Designation and is not listed or traded on the NASDAQ Stock Market, LLC.  

 

About Ecofibre

Ecofibre is a provider of hemp products in the United States and Australia.

In the United States, the Company produces nutraceutical products for human and pet consumption, as well as topical creams and salves. See www.anandahemp.com and www.anandaprofessional.com.

In Australia, the Company produces 100% Australian grown and processed hemp food products including protein powders, de-hulled hemp seed, and hemp oil. See www.anandafood.com.

The Company is also developing innovative hemp-based products in textiles and composite materials in partnership with Thomas Jefferson University (TJU) in the United States. See www.hempblack.com.

The Company owns or controls key parts of the value chain in each business, from breeding, growing, and production to sales and marketing. Our value proposition to customers is built on strong brands and quality products. 

 

###



Jonathan Brown, Company Secretary
Ecofibre Limited
[email protected]

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Turquoise Hill Resources Ltd. (TRQ)

LOS ANGELES, Nov. 16, 2020 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 14, 2020 to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Turquoise Hill Resources Ltd. (“Turquoise Hill” or the “Company”) (NYSE: TRQ) securities between July 17, 2018 and July 31, 2019, inclusive (the “Class Period”).

If you suffered a loss on your Turquoise Hill investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/turquoise-hill-resources-ltd/.

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

On February 26, 2019, the Company announced in a press release that, while “the [Oyu Tolgoi] project cost was expected to remain within the $5.3 billion budget,” a review had determined that “there was an increasingly likely risk of a further delay to sustainable first production beyond Q3‘21.” Turquoise Hill attributed the “likely risk” to productivity setbacks in completing Shaft 2 and “challenging ground conditions that have had a direct impact on the project’s critical path.”

On this news, the Company’s share price fell $0.27, or approximately 13%, to close at $1.83 per share on February 27, 2019, thereby injuring investors.

Then, on July 15, 2019, Turquoise Hill announced that sustainable first production from the underground development of Oyu Tolgoi would now be delayed by another 9 to 21 months until May 2022 to June 2023. The Company also stated that “the development capital spend for the project may increase by $1.2 to $1.9 billion over the $5.3 billion previously disclosed.”

On this news, the Company’s share price fell $0.47, or 44%, to close at $0.60 per share on July 16, 2019, thereby injuring investors further.

Then, on July 31, 2019, after the market closed, Turquoise Hill disclosed that it had taken a $600 million impairment charge and a significant “deferred income tax recognition adjustment” tied to the Oyu Tolgoi project, and that it had suffered a loss in the second quarter.

On this news, the Company’s share price fell $0.05, or over 8%, to close at $0.53 per share on August 1, 2019, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the production of underground development of Oyu Tolgoi was not proceeding as planned; (2) there were substantial undisclosed underground stability problems that called into question the design of the mine and the projected cost and timing of production; (3) Turquoise Hill’s publicly released estimates of the cost, date of completion, and dates for production from the underground mine were not attainable; (4) the development capital required for the underground development of Oyu Tolgoi would cost substantially more than a billion dollars over what Turquoise Hill had represented; (5) Turquoise Hill would require additional financing and/or equity to complete the project; and (6) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.   

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Turquoise Hill securities during the Class Period, you may move the Court no later than December 14, 2020 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com  
[email protected]

 



DEADLINE ALERT for GTX, GTXMQ, BMRN, BTU, PT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM, Pa., Nov. 16, 2020 (GLOBE NEWSWIRE) — Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected].

Garrett Motion Inc. (NYSE: GTX, OTC: GTXMQ)
Class Period: October 1, 2018 – September 18, 2020
Lead Plaintiff Deadline: November 24, 2020

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that, due to its agreement to indemnify and reimburse Honeywell for certain asbestos-related liability, Garrett was saddled with an unsustainable level of debt; (2) that, as a result, Garrett had a highly leveraged capital structure that posed significant challenges to its overall strategic and financial flexibility; (3) that, as a result of the foregoing, Garrett’s ability to gain or hold market share was impaired; (4) that, as a result of the foregoing, the Company was reasonably likely to seek bankruptcy protection; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. 

BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN)
Class Period: February 28, 2020 – August 18,2020
Lead Plaintiff Deadline:  November 24, 2020

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the differences between the Phase 1/2 and Phase 3 study of valoctocogene roxaparvovec limited the reliability of the Phase 1/2 study to support valoctocogene roxaparvovec’s durability of effect; (2) as a result, it was foreseeable that the FDA would not approve the BLA for valoctocogene roxaparvovec without further data; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Peabody Energy Corporation (NYSE: BTU)
Class Period: April 3, 2017 – October 28, 2019
Lead Plaintiff Deadline: November 27, 2020


Shareholders with $250,000 losses or more are encouraged to contact the firm

The complaint alleges that Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Peabody had failed to implement adequate safety controls at the North Goonyella mine to prevent the risk of a spontaneous combustion event; (2) Peabody failed to follow its own safety procedures; (3) as a result, the North Goonyella mine was at a heightened risk of shutdown; (4) Peabody’s low-cost plan to restart operations at the North Goonyella mine posed unreasonable safety and environmental risks; (5) the Queensland Mines Inspectorate (“QMI”), the Australian body responsible for ensuring acceptable health and safety standards, would likely mandate a safer, cost-prohibitive approach; (6) as a result, there would be major delays in reopening the North Goonyella mine and restarting coal production; and (7) that, as a result, of the foregoing, Defendants’ statements about the Peabody’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Pintec Technology Holdings Limited (NASDAQ: PT)
IPO: October 2018
Lead Plaintiff Deadline: November 30, 2020

The complaint alleges that the Registration Statement was false and misleading and omitted to state material facts. Specifically, Defendants failed to disclose to investors: (1) that Pintec erroneously recorded revenue earned from certain technical service fee on a net basis, rather than a gross basis; (2) that there were material weaknesses in the Company’s internal control over financial reporting related to cash advances outside the normal course of business to Jimu Group, a related party, and to a non-routine loan financing transaction with a third-party entity, Plutux Labs; (3) that, as a result of the foregoing, Pintec’s financial results for fiscal 2017 and 2018 had been misstated; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Pintec’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis

To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
[email protected]
www.howardsmithlaw.com



Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Evolus, Inc. (EOLS)

LOS ANGELES, Nov. 16, 2020 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 15, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Evolus, Inc.(“Evolus” or the “Company”) (NASDAQ: EOLS) securities between February 1, 2019 and July 6, 2020, inclusive (the “Class Period”).

If you suffered a loss on your Evolus investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/evolus-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Evolus is a direct competitor with Botox, which is manufactured by Allergan plc and Allergan Inc. (collectively, “Allergan”) and distributed by Medytox Inc. (“Medytox”). Botox has been the gold standard of the industry since its approval by the U.S. Food and Drug Administration (“FDA”) more than twenty years ago. 

On July 6, 2020, the Initial Final Determination was issued by the U.S. International Trade Commission (“ITC”) in a case brought by Allergan and Medytox against Evolus, asserting that Evolus stole certain trade secrets to develop Jeuveau™. The ITC Judge determined that the Company misappropriated the botulinum toxin strain as well as the manufacturing processes that led to its development and manufacture. As a result, the ITC Judge recommended a ten-year long ban on the Company’s ability to import Jeuveau™ into the United States and a ten-year long cease and desist order preventing Evolus from selling Jeuveau™ in the United States.

On this news, the Company’s share price declined significantly, falling 37% over the course of two trading days, to close at $3.35 on July 8, 2020, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the real source of botulinum toxin bacterial strain, along with the manufacturing processes used to develop Jeuveau, originated with and were misappropriated from Medytox; (2) sufficient evidentiary support existed for the allegations that the Company misappropriated certain trade secrets relating to the botulin toxin strain and the manufacturing processes for the development of Jeuveau; (3) as a result, the Company faced a real threat of regulatory and/or court action, barring the import, marketing, and sale of Jeuveau; which in turn (4) seriously threatened Evolus’ ability to commercialize Jeuveau in the United States and generate revenue; and (5) any revenues generated from the sale of Jeuveau were based on Evolus’ unlawful actions, including the misappropriation of trade secrets and secret manufacturing processes belonging to Allergan and Medytox; and (6) that, as a result, the Company’s public statements were materially false and misleading at all relevant times.

If you purchased or otherwise acquired Evolus securities during the Class Period, you may move the Court no later than December 15, 2020 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

Follow us for updates on LinkedIn, Twitter, or Facebook.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com  
[email protected]



Wilsonart Unveils New Laminate Collection Designed to Enhance Wellness

The 2020 Virtual Design Library offers textures and colors that help bring calm and relaxation to healthcare settings

TEMPLE, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) — As interior design that prioritizes mindfulness and comfort becomes increasingly important, Wilsonart continues to push the practice forward with its 2020 Virtual Design Library. Embracing the concept of “Wellness,” the new curated collection of boutique laminate designs takes inspiration from nature and brings healing, calm, and serenity to healthcare-built environments and beyond.

Based on research that suggests a strong connection between well-being and familiar elements found in the natural world, these new Wellness offerings feature organic patterns, textures, and colors. From large-scale abstract scenes reminiscent of foggy grey mountains to layered sky motifs that exude warmth, all are designed to soothe the soul and invigorate the senses. This collection also introduces the Hinoki range, consisting of three neutral-hued woodgrains that get their name from Japanese cypress trees famous for their “divine wood.”

“The concept of wellness has rippled through communities and industries as people look for a bit of respite from the stresses of modern life. We’re proud to offer intentional design coupled with high performance that can bring tranquility to healthcare settings,” says Danielle Mikesell, Global Vice President of Marketing and Design for Wilsonart. “The best part is that while these looks were created with healthcare in mind, they also work beautifully for hospitality, retail, and residential.”

Extending the 2020 Virtual Design Library umbrella theme of “Community,” the Wellness collection offers individual appeal — while also harmonizing to create a unique palette. Their coordinating possibilities increase exponentially when combined with Wilsonart’s engineered surfaces portfolio, including Wilsonart® Quartz, Solid Surface, High Pressure Laminate (HPL), and Coordinated Surfaces. This flexibility helps facilities quickly adapt to new modes of care.

Staying true to the durability and easy maintenance Wilsonart is known for, the 2020 Virtual Design Library Wellness collection also offers exceptional cleanability and resistance to scratches and scuffs for lasting beauty and high-quality appearance.

Learn more about the Virtual Design Library Wellness collection.

About Wilsonart


Wilsonart
, a world-leading engineered surfaces company, is driven by a mission to create surfaces people love, with service they can count on, delivered by people who care. The Company manufactures and distributes High Pressure Laminate, Quartz, Solid Surface, Coordinated TFL and Edgebanding and other decorative engineered surfaces for use in the office, education, healthcare, residential, hospitality, and retail markets. Operating under the Wilsonart®, Arborite®, Bushboard, Durcon®, KML®, Laminart®, Mermaid, New Leaf, Polyrey®, Ralph Wilson®, Resopal®, Shore, Technistone® and Wetwall brands, the company continuously redefines decorative surfaces through improved performance and award-winning designs. For more information and samples visit www.wilsonart.com or connect with us on Facebook, Houzz, Pinterest, Instagram, Twitter, LinkedIn, and YouTube.

Tammy Weadock
[email protected]
(254) 207-3444

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d72333c1-a08d-4ce4-af09-c0e886efb055



Park Aeropsace Corp. Announces Ben Shore is Leaving the Company

NEWTON, Kansas, Nov. 16, 2020 (GLOBE NEWSWIRE) — Park Aerospace Corp. (NYSE-PKE) announced that Ben Shore, the Company’s Senior Vice President of Sales, Marketing and Business Development, has decided to leave the Company. Ben’s last day with the Company is planned to be December 23, 2020.

Brian Shore, Park’s Chairman and CEO, said, “Ben is a great guy and a very smart guy. All of us who worked with him at Park very much enjoyed and appreciated being able to do so. It has been a real pleasure for us. We all wish Ben well in his future endeavors. We also all wish Ben the best of luck, which he likely will not need. Thanks Ben. It has been great working with you!”

Park Aerospace Corp. develops and manufactures solution and hot-melt advanced composite materials used to produce composite structures for the global aerospace markets. Park’s advanced composite materials include film adhesives (undergoing qualification) and lightning strike materials. Park offers an array of composite materials specifically designed for hand lay-up or automated fiber placement (AFP) manufacturing applications. Park’s advanced composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as “drones”), business jets, general aviation aircraft and rotary wing aircraft. Park also offers specialty ablative materials for rocket motors and nozzles and specially designed materials for radome applications. As a complement to Park’s advanced composite materials offering, Park designs and fabricates composite parts, structures and assemblies and low volume tooling for the aerospace industry. Target markets for Park’s composite parts and structures (which include Park’s proprietary composite SigmaStrut™ and AlphaStrut™ product lines) are, among others, prototype and development aircraft, special mission aircraft, spares for legacy military and civilian aircraft and exotic spacecraft. Park’s objective is to do what others are either unwilling or unable to do. When nobody else wants to do it because it is too difficult, too small or too annoying, sign us up.

Additional corporation information is available on the Company’s web site at www.parkaerospace.com.

Contact: Donna D’Amico-Annitto 486 North Oliver Road, Bldg. Z 
    Newton, Kansas 67114
    (316) 283-6500



NRG Energy, Inc. Announces Proposed Offerings of Senior Secured First Lien Notes, Senior Unsecured Notes and Pre-Capitalized Trust Securities

NRG Energy, Inc. Announces Proposed Offerings of Senior Secured First Lien Notes, Senior Unsecured Notes and Pre-Capitalized Trust Securities

PRINCETON, N.J.–(BUSINESS WIRE)–
NRG Energy, Inc. (NYSE:NRG) intends to commence concurrent offerings of (i) senior secured first lien notes, consisting of senior secured first lien notes due 2025 (the “2025 Secured Notes”) and senior secured first lien notes due 2027 (the “2027 Secured Notes” and, together with the 2025 Secured Notes, the “Secured Notes”), and (ii) senior unsecured notes, consisting of senior unsecured notes due 2029 and senior unsecured notes due 2031 (collectively, with the Secured Notes, the “Notes”). The 2027 Secured Notes are being issued under NRG’s Sustainability-Linked Bond Framework, which sets out certain sustainability targets, including reducing greenhouse gas emissions.

NRG intends to use the net proceeds from the offerings of the Notes (the “Notes Offerings”), together with cash on hand, to fund the purchase price of the previously announced acquisition (the “Acquisition”) of Direct Energy, the North American energy supply, services and trading business of Centrica plc (“Centrica”), pursuant to the previously disclosed Purchase Agreement, dated July 24, 2020, among NRG, Centrica and certain of Centrica’s subsidiaries (the “Purchase Agreement”), and to pay fees and expenses relating to the Acquisition, if consummated, and the Notes Offerings.

Concurrently with the Notes Offerings, Alexander Funding Trust, a newly-formed Delaware statutory trust (the “Trust”), intends to issue pre-capitalized trust securities redeemable 2023 (the “P-Caps”) in a private offering to certain qualified institutional buyers. The Trust will initially invest the proceeds from the sale of the P-Caps in a portfolio of principal and/or interest strips of U.S. Treasury securities (the “Eligible Assets”) and will enter into a facility agreement with NRG under which NRG will pay a periodic premium to the Trust, and NRG will agree to issue senior secured notes due 2023 (the “P-Caps Secured Notes” and, together with the P-Caps, the “P-Caps Securities”) to the Trust under certain circumstances. The Eligible Assets held by the Trust will be used to provide collateral to certain banks that have agreed to provide letters of credit for NRG’s account to support NRG’s existing and future collateral obligations, including following consummation of the Acquisition. NRG will not receive any proceeds directly from the offering of the P-Caps.

If the Acquisition is not consummated, or the Purchase Agreement is terminated, on or before July 24, 2021 (or, certain later dates pursuant to the automatic extension provisions of the Purchase Agreement, as applicable) (such event, an “Acquisition Triggering Event”), then NRG will be required to redeem, within 30 days of the Acquisition Triggering Event, a specified aggregate principal amount of the senior unsecured notes due 2029 and a specified aggregate principal amount of the senior unsecured notes due 2031, in each case, at a redemption price equal to 100% of the principal amount thereof, plus accrued and unpaid interest to, but not including, the redemption date. In addition, the Trust will mandatorily redeem all of the P-Caps at a redemption price equal to 101% of the principal amount thereof, plus accrued and unpaid interest to, but not including, the redemption date.

The Notes will be guaranteed on a first-priority basis by each of NRG’s current and future subsidiaries that guarantee indebtedness under its credit agreement. The Secured Notes, and any P-Caps Secured Notes, will be secured by a first priority security interest in the same collateral that is pledged for the benefit of the lenders under NRG’s credit agreement, which consists of a substantial portion of the property and assets owned by NRG and the guarantors. The collateral securing the Secured Notes and any P-Caps Secured Notes will be released if NRG obtains an investment grade rating from two out of the three rating agencies, subject to reversion if such rating agencies withdraw NRG’s investment grade rating or downgrade NRG’s rating below investment grade. The new senior unsecured notes will be senior unsecured obligations of NRG and will be guaranteed by the same subsidiaries that guarantee indebtedness under NRG’s credit agreement.

The Notes and related guarantees, as well as the P-Caps Securities, are being offered only to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), or in the case of the Notes and related guarantees, outside the United States, to persons other than “U.S. persons” in compliance with Regulation S under the Securities Act. The Notes and related guarantees, as well as the P-Caps Securities, have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

This press release does not constitute an offer to sell any security, including the Notes and the P-Caps Securities, nor a solicitation for an offer to purchase any security, including the Notes and the P-Caps Securities.

About NRG

At NRG, we’re bringing the power of energy to people and organizations by putting customers at the center of everything we do. We generate electricity and provide energy solutions and natural gas to more than 3.7 million residential, small business, and commercial and industrial customers through our diverse portfolio of retail brands. A Fortune 500 company, operating in the United States and Canada, NRG delivers innovative solutions while advocating for competitive energy markets and customer choice, and by working towards a sustainable energy future.

Forward-Looking Statements

This communication contains forward-looking statements that may state NRG’s or its management’s intentions, beliefs, expectations or predictions for the future. Such forward-looking statements are subject to certain risks, uncertainties and assumptions, and typically can be identified by the use of words such as “will,” “expect,” “estimate,” “anticipate,” “forecast,” “plan,” “believe” and similar terms. Although NRG believes that its expectations are reasonable, it can give no assurance that these expectations will prove to have been correct, and actual results may vary materially. Factors that could cause actual results to differ materially from those contemplated above include, among others, risks and uncertainties related to the capital markets generally and whether the Notes Offerings or the offering of P-Caps will be consummated, the anticipated terms of the Notes and the P-Caps, and the anticipated use of proceeds, including the consummation of the Acquisition.

The foregoing review of factors that could cause NRG’s actual results to differ materially from those contemplated in the forward-looking statements included herein should be considered in connection with information regarding risks and uncertainties that may affect NRG’s future results included in NRG’s filings with the SEC at www.sec.gov.

Investors:

Kevin L. Cole, CFA

609.524.4526

[email protected]

Media:

Candice Adams

609.524.5428

[email protected]

KEYWORDS: New Jersey United States North America

INDUSTRY KEYWORDS: Other Energy Utilities Oil/Gas Coal Alternative Energy Energy Nuclear

MEDIA: